STOCK TITAN

Incyte to Present at Upcoming Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Incyte will present at the 2022 RBC Capital Markets Healthcare Conference on May 17, 2022, at 10:30 a.m. ET in New York. The presentation will be available via live webcast on Investor.Incyte.com and can be replayed for 30 days. Based in Wilmington, Delaware, Incyte is a global biopharmaceutical company committed to addressing serious unmet medical needs through proprietary therapeutics. For more information, visit Incyte.com.

Positive
  • None.
Negative
  • None.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it will present at the 2022 RBC Capital Markets Healthcare Conference on Tuesday, May 17, 2022 at 10:30 a.m. ET in New York.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Media

Catalina Loveman

+1 302 498 6171

cloveman@incyte.com



Investors

Christine Chiou

+1 302 274 4773

cchiou@incyte.com

Source: Incyte

FAQ

When is Incyte's presentation at the RBC Capital Markets Healthcare Conference?

Incyte's presentation is scheduled for May 17, 2022, at 10:30 a.m. ET.

Where can I watch Incyte's presentation live?

The presentation will be webcast live on Investor.Incyte.com.

How long will the Incyte presentation replay be available?

The replay of Incyte's presentation will be available for 30 days.

What is Incyte's focus as a biopharmaceutical company?

Incyte focuses on finding solutions for serious unmet medical needs through the discovery and development of proprietary therapeutics.

Where is Incyte headquartered?

Incyte is headquartered in Wilmington, Delaware.

Incyte Genomics Inc

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Stock Data

13.56B
188.30M
2.04%
97.86%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States of America
WILMINGTON